PAREXEL International to Participate at Cowen & Co. Health Care Conference and Barclays Global Healthcare Conference
BOSTON, February 22, 2017 – PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be participating at two investor conferences in March.
- Emma Reeve, Corporate Vice President and Interim Chief Financial Officer, will meet with investors at the Cowen and Company Health Care Conference on Monday, March 6, 2017, in Boston.
- Josef von Rickenbach, Chairman and Chief Executive Officer, will present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017 at 4:20pm ET, in Miami.
A live webcast of the Barclays presentation will be available at PAREXEL’s website at www.PAREXEL.com on the Investors / Events and Presentations webpage. A replay of the presentation will be available on the website for 90 days after the presentation.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 85 locations in 51 countries around the world, and had approximately 19,625 employees in the second quarter. For more information about PAREXEL International visit www.PAREXEL.com.
Tel.: + 1-781-434-4753 or +1-781-434-8465
Tel.: + 1-781-434-4772